Humana Inc (HUM)

(A Top Pick Sep 03/19, Up 45%) He bought it 18 months ago, when there were worries about Democratic candidates who may pressure U.S. medical insurance. The Medicare advantage is a serious tailwind given aging demographics in coming years--a lot of people will buy this insurance and Humana sits in the sweet spot. There'll be volatility in this space before the November vote, but medical insurance will remain a force. He sold some shares, but still likes this stock and sees a good long term.

It is in a very interesting part of the insurance space in the US, focusing on Medicare. 10,000 people a day in the US are turning 65. The demographic tailwind is going to be huge. This is part of the healthcare market he really likes. (Analysts’ price target is $327.14)

There's great opportunity in U.S. health insurers. But Pressure from politicians ahead of the 2020 election are pressuring drug and health stocks. He doesn't believe the State will go to nationalized healthcare, as the Democrats want. Humana is a Medicare Advantage provider; over 70% of revenue comes from here, and Americans are aging--demographics favour Humana. (Analysts’ price target is $334.86)

Likes the Health Management Sector.